{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T09:03:14Z","timestamp":1725872594397},"publisher-location":"New York, NY","reference-count":49,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493967018"},{"type":"electronic","value":"9781493967032"}],"license":[{"start":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T00:00:00Z","timestamp":1480636800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-6703-2_22","type":"book-chapter","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T23:22:31Z","timestamp":1480548151000},"page":"279-293","source":"Crossref","is-referenced-by-count":13,"title":["Recurrent Cytogenetic Abnormalities in Non-Hodgkin\u2019s Lymphoma and Chronic Lymphocytic Leukemia"],"prefix":"10.1007","author":[{"given":"Edmond S. K.","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,2]]},"reference":[{"key":"22_CR1","unstructured":"Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms. Blood pii: blood-2016-01-643569"},{"issue":"2","key":"22_CR2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.humpath.2006.08.022","volume":"38","author":"MA Belaud-Rotureau","year":"2007","unstructured":"Belaud-Rotureau MA, Parrens M, Carrere N et al (2007) Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma. Hum Pathol 38(2):365\u2013372","journal-title":"Hum Pathol"},{"issue":"5","key":"22_CR3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.leukres.2007.09.010","volume":"32","author":"B Espinet","year":"2008","unstructured":"Espinet B, Bellosillo B, Melero C et al (2008) FISH is better than BIOMED-2 PCR to detect IgH\/BCL2 translocation in follicular lymphoma at diagnosis using paraffin-embedded tissue sections. Leuk Res 32(5):737\u2013742","journal-title":"Leuk Res"},{"issue":"12","key":"22_CR4","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ Dongen van","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Bruggemann M et al (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17(12):2257\u20132317","journal-title":"Leukemia"},{"issue":"26","key":"22_CR5","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H Dohner","year":"2000","unstructured":"Dohner H, Stilgenbauer S, Benner A et al (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343(26):1910\u20131916","journal-title":"N Engl J Med"},{"issue":"2","key":"22_CR6","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2005-05-2093","volume":"107","author":"C Mayr","year":"2006","unstructured":"Mayr C, Speicher MR, Kofler DM et al (2006) Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood 107(2):742\u2013751","journal-title":"Blood"},{"issue":"1","key":"22_CR7","first-page":"36","volume":"63","author":"JC Byrd","year":"2003","unstructured":"Byrd JC, Smith L, Hackbarth ML et al (2003) Interphase cytogenetic abnormalities in chronic lymphocytic leukemia may predict response to rituximab. Cancer Res 63(1):36\u201338","journal-title":"Cancer Res"},{"issue":"14","key":"22_CR8","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1002\/cncr.26593","volume":"118","author":"R Garg","year":"2012","unstructured":"Garg R, Wierda W, Ferrajoli A et al (2012) The prognostic difference of monoallelic versus biallelic deletion of 13q in chronic lymphocytic leukemia. Cancer 118(14):3531\u20133537","journal-title":"Cancer"},{"issue":"29","key":"22_CR9","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1200\/JCO.2009.27.8762","volume":"28","author":"T Zenz","year":"2010","unstructured":"Zenz T, Eichhorst B, Busch R et al (2010) TP53 mutation and survival in chronic lymphocytic leukemia. J Clin Oncol 28(29):4473\u20134479","journal-title":"J Clin Oncol"},{"issue":"9","key":"22_CR10","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1182\/blood-2003-10-3729","volume":"103","author":"G Lozanski","year":"2004","unstructured":"Lozanski G, Heerema NA, Flinn IW et al (2004) Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions. Blood 103(9):3278\u20133281","journal-title":"Blood"},{"issue":"1","key":"22_CR11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood-2014-02-556399","volume":"124","author":"N Pflug","year":"2014","unstructured":"Pflug N, Bahlo J, Shanafelt TD et al (2014) Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia. Blood 124(1):49\u201362","journal-title":"Blood"},{"issue":"6","key":"22_CR12","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/sj.leu.2403738","volume":"19","author":"Y Guo","year":"2005","unstructured":"Guo Y, Karube K, Kawano R et al (2005) Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances. Leukemia 19(6):1058\u20131063","journal-title":"Leukemia"},{"issue":"5","key":"22_CR13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","volume":"113","author":"T Katzenberger","year":"2009","unstructured":"Katzenberger T, Kalla J, Leich E et al (2009) A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood 113(5):1053\u20131061","journal-title":"Blood"},{"issue":"10","key":"22_CR14","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood.V99.10.3735","volume":"99","author":"R Fonseca","year":"2002","unstructured":"Fonseca R, Blood EA, Oken MM et al (2002) Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients. Blood 99(10):3735\u20133741","journal-title":"Blood"},{"issue":"18","key":"22_CR15","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2014-01-550905","volume":"123","author":"SP Treon","year":"2014","unstructured":"Treon SP, Cao Y, Xu L et al (2014) Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia. Blood 123(18):2791\u20132796","journal-title":"Blood"},{"issue":"24","key":"22_CR16","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","volume":"364","author":"E Tiacci","year":"2011","unstructured":"Tiacci E, Trifonov V, Schiavoni G et al (2011) BRAF mutations in hairy-cell leukemia. N Engl J Med 364(24):2305\u20132315","journal-title":"N Engl J Med"},{"issue":"9249","key":"22_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(00)03571-6","volume":"357","author":"H Liu","year":"2001","unstructured":"Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A et al (2001) Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 357(9249):39\u201340","journal-title":"Lancet"},{"issue":"25","key":"22_CR18","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald A, Wright G, Chan WC et al (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346(25):1937\u20131947","journal-title":"N Engl J Med"},{"issue":"2","key":"22_CR19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.2010.30.0368","volume":"29","author":"PN Meyer","year":"2011","unstructured":"Meyer PN, Fu K, Greiner TC et al (2011) Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol 29(2):200\u2013207","journal-title":"J Clin Oncol"},{"issue":"8","key":"22_CR20","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","volume":"123","author":"DW Scott","year":"2014","unstructured":"Scott DW, Wright GW, Williams PM et al (2014) Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. Blood 123(8):1214\u20131217","journal-title":"Blood"},{"issue":"2","key":"22_CR21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/leu.2008.281","volume":"23","author":"EG Boerma","year":"2009","unstructured":"Boerma EG, Siebert R, Kluin PM et al (2009) Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of today's knowledge. Leukemia 23(2):225\u2013234","journal-title":"Leukemia"},{"issue":"4","key":"22_CR22","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12185-013-1414-9","volume":"98","author":"CC So","year":"2013","unstructured":"So CC, Yung KH, Chu ML et al (2013) Diagnostic challenges in a case of B cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. Int J Hematol 98(4):478\u2013482","journal-title":"Int J Hematol"},{"issue":"28","key":"22_CR23","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1200\/JCO.2012.43.5800","volume":"30","author":"JW Friedberg","year":"2012","unstructured":"Friedberg JW (2012) Double-hit diffuse large B-cell lymphoma. J Clin Oncol 30(28):3439\u20133443","journal-title":"J Clin Oncol"},{"issue":"7","key":"22_CR24","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/modpathol.2013.214","volume":"27","author":"A Tzankov","year":"2014","unstructured":"Tzankov A, Xu-Monette ZY, Gerhard M et al (2014) Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol 27(7):958\u2013971","journal-title":"Mod Pathol"},{"issue":"1","key":"22_CR25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ejh.12212","volume":"92","author":"MO Pedersen","year":"2014","unstructured":"Pedersen MO, Gang AO, Poulsen TS et al (2014) MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC\/BCL2 translocations. Eur J Haematol 92(1):42\u201348","journal-title":"Eur J Haematol"},{"issue":"12","key":"22_CR26","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","volume":"121","author":"H Horn","year":"2013","unstructured":"Horn H, Ziepert M, Becher C et al (2013) MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood 121(12):2253\u20132263","journal-title":"Blood"},{"issue":"20","key":"22_CR27","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","volume":"121","author":"S Hu","year":"2013","unstructured":"Hu S, Xu-Monette ZY, Tzankov A et al (2013) MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program. Blood 121(20):4021\u20134031","journal-title":"Blood"},{"issue":"2","key":"22_CR28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.leu.2404481","volume":"21","author":"M Bruggemann","year":"2007","unstructured":"Bruggemann M, White H, Gaulard P et al (2007) Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies. Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia 21(2):215\u2013221","journal-title":"Leukemia"},{"issue":"10","key":"22_CR29","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1002\/eji.200425146","volume":"34","author":"V Pascal","year":"2004","unstructured":"Pascal V, Schleinitz N, Brunet C et al (2004) Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions. Eur J Immunol 34(10):2930\u20132940","journal-title":"Eur J Immunol"},{"issue":"5151","key":"22_CR30","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","volume":"263","author":"SW Morris","year":"1994","unstructured":"Morris SW, Kirstein MN, Valentine MB et al (1994) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma. Science 263(5151):1281\u20131284","journal-title":"Science"},{"issue":"12","key":"22_CR31","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","volume":"111","author":"KJ Savage","year":"2008","unstructured":"Savage KJ, Harris NL, Vose JM et al (2008) ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 111(12):5496\u20135504","journal-title":"Blood"},{"issue":"4","key":"22_CR32","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.leu.2402884","volume":"17","author":"S Gesk","year":"2003","unstructured":"Gesk S, Martin-Subero JI, Harder L et al (2003) Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci. Leukemia 17(4):738\u2013745","journal-title":"Leukemia"},{"issue":"3","key":"22_CR33","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/leu.2008.320","volume":"23","author":"AL Feldman","year":"2009","unstructured":"Feldman AL, Law M, Remstein ED et al (2009) Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia 23(3):574\u2013580","journal-title":"Leukemia"},{"issue":"4","key":"22_CR34","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","volume":"24","author":"DA Wada","year":"2011","unstructured":"Wada DA, Law ME, Hsi ED et al (2011) Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies. Mod Pathol 24(4):596\u2013605","journal-title":"Mod Pathol"},{"issue":"3","key":"22_CR35","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","volume":"117","author":"AL Feldman","year":"2011","unstructured":"Feldman AL, Dogan A, Smith DI et al (2011) Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood 117(3):915\u2013919","journal-title":"Blood"},{"issue":"11","key":"22_CR36","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","volume":"120","author":"G Vasmatzis","year":"2012","unstructured":"Vasmatzis G, Johnson SH, Knudson RA et al (2012) Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood 120(11):2280\u20132289","journal-title":"Blood"},{"issue":"9","key":"22_CR37","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","volume":"124","author":"ER Parrilla Castellar","year":"2014","unstructured":"Parrilla Castellar ER, Jaffe ES, Said JW et al (2014) ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood 124(9):1473\u20131480","journal-title":"Blood"},{"issue":"2","key":"22_CR38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","volume":"20","author":"B Streubel","year":"2006","unstructured":"Streubel B, Vinatzer U, Willheim M et al (2006) Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 20(2):313\u2013318","journal-title":"Leukemia"},{"issue":"3","key":"22_CR39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/gcc.10021","volume":"33","author":"I Wlodarska","year":"2002","unstructured":"Wlodarska I, Martin-Garcia N, Achten R et al (2002) Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression. Genes Chromosomes Cancer 33(3):243\u2013251","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"22_CR40","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)65454-5","volume":"155","author":"LL Siu","year":"1999","unstructured":"Siu LL, Wong KF, Chan JK et al (1999) Comparative genomic hybridization analysis of natural killer cell lymphoma\/leukemia. Recognition of consistent patterns of genetic alterations. Am J Pathol 155(5):1419\u20131425","journal-title":"Am J Pathol"},{"issue":"6","key":"22_CR41","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0002-9440(10)64818-3","volume":"157","author":"LL Siu","year":"2000","unstructured":"Siu LL, Chan V, Chan JK et al (2000) Consistent patterns of allelic loss in natural killer cell lymphoma. Am J Pathol 157(6):1803\u20131809","journal-title":"Am J Pathol"},{"issue":"6","key":"22_CR42","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2009.3","volume":"23","author":"J Iqbal","year":"2009","unstructured":"Iqbal J, Kucuk C, Deleeuw RJ et al (2009) Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia 23(6):1139\u20131151","journal-title":"Leukemia"},{"issue":"6","key":"22_CR43","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","volume":"115","author":"Y Huang","year":"2010","unstructured":"Huang Y, de RA, de LL et al (2010) Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type. Blood 115(6):1226\u20131237","journal-title":"Blood"},{"issue":"5","key":"22_CR44","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","volume":"132","author":"RJ Deleeuw","year":"2007","unstructured":"Deleeuw RJ, Zettl A, Klinker E et al (2007) Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 132(5):1902\u20131911","journal-title":"Gastroenterology"},{"issue":"4","key":"22_CR45","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s00428-005-1214-6","volume":"446","author":"P Cejkova","year":"2005","unstructured":"Cejkova P, Zettl A, Baumgartner AK et al (2005) Amplification of NOTCH1 and ABL1 gene loci is a frequent aberration in enteropathy-type T-cell lymphoma. Virchows Arch 446(4):416\u2013420","journal-title":"Virchows Arch"},{"key":"22_CR46","doi-asserted-by":"crossref","unstructured":"Yoo HY, Kim P, Kim WS et al. (2016) Frequent CTLA4-CD28 gene fusion in diverse types of T cell lymphoma. Haematologica. pii: haematol.2015.139253","DOI":"10.3324\/haematol.2015.139253"},{"issue":"10","key":"22_CR47","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","volume":"109","author":"JG Lohr","year":"2012","unstructured":"Lohr JG, Stojanov P, Lawrence MS et al (2012) Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A 109(10):3879\u20133884","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"22_CR48","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","volume":"365","author":"L Wang","year":"2011","unstructured":"Wang L, Lawrence MS, Wan Y et al (2011) SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 365(26):2497\u20132506","journal-title":"N Engl J Med"},{"issue":"18","key":"22_CR49","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJMoa1506583","volume":"373","author":"E Tiacci","year":"2015","unstructured":"Tiacci E, Park JH, De CL et al (2015) Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia. N Engl J Med 373(18):1733\u20131747","journal-title":"N Engl J Med"}],"container-title":["Methods in Molecular Biology","Cancer Cytogenetics"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-6703-2_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T00:56:51Z","timestamp":1498352211000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-6703-2_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,2]]},"ISBN":["9781493967018","9781493967032"],"references-count":49,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-6703-2_22","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2016,12,2]]}}}